Literature DB >> 10915743

Human homologue of maid: A dominant inhibitory helix-loop-helix protein associated with liver-specific gene expression.

S Terai1, H Aoki, K Ashida, S S Thorgeirsson.   

Abstract

The helix-loop-helix (HLH) family of transcriptional regulatory proteins are key regulators in numerous developmental processes. The class I HLH proteins, such as E12 are ubiquitously expressed. Class II HLH proteins, such as MyoD, are expressed in a tissue-specific manner. Class I and II heterodimers can bind to E-boxes (CANNTG) and regulate lineage commitments of embryonic cells. In an attempt to identify partners for the E12 protein that may exert control during liver development, we performed the yeast 2-hybrid screen using an expression complementary DNA library from human fetal liver. A novel dominant inhibitory HLH factor, designated HHM (human homologue of maid), was isolated and characterized. HHM is structurally related to the Id family and was highly expressed in brain, pituitary gland, lung, heart, placenta, fetal liver, and bone marrow. HHM physically interacted with E12 in vitro and in mammalian cells. Comparison of the dominant inhibitory effects of HHM and Id2 on the binding of E12/MyoD dimer to an E-box element revealed a weaker inhibition by HHM. However, HHM but not Id2 specifically inhibited the luciferase gene activation induced by hepatic nuclear factor 4 (HNF4) promoter. The HHM was transiently expressed during stem-cell-driven regeneration of the liver at the stage in which the early basophilic foci of hepatocytes started to appear. These results suggest that HHM is a novel type of dominant inhibitory HLH protein that might modulate liver-specific gene expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10915743     DOI: 10.1053/jhep.2000.9092

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  10 in total

1.  Crystallization and preliminary X-ray diffraction analysis of GCIP/HHM transcriptional regulator.

Authors:  Azusa Seto; Hiroaki Ikushima; Toshiyasu Suzuki; Yusuke Sato; Shuya Fukai; Keiko Yuki; Keiji Miyazawa; Kohei Miyazono; Ryuichiro Ishitani; Osamu Nureki
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-12-25

2.  Structure of a dominant-negative helix-loop-helix transcriptional regulator suggests mechanisms of autoinhibition.

Authors:  Ryohei Ishii; Kazunobu Isogaya; Azusa Seto; Daizo Koinuma; Yuji Watanabe; Fumio Arisaka; So-ichi Yaguchi; Hiroaki Ikushima; Naoshi Dohmae; Kohei Miyazono; Keiji Miyazawa; Ryuichiro Ishitani; Osamu Nureki
Journal:  EMBO J       Date:  2012-03-27       Impact factor: 11.598

3.  Involvement of DNA Damage Response via the Ccndbp1-Atm-Chk2 Pathway in Mice with Dextran-Sodium-Sulfate-Induced Colitis.

Authors:  Ryoko Horigome; Kenya Kamimura; Yusuke Niwa; Kohei Ogawa; Ken-Ichi Mizuno; Koichi Fujisawa; Naoki Yamamoto; Taro Takami; Tomoyuki Sugano; Akira Sakamaki; Hiroteru Kamimura; Masaaki Takamura; Shuji Terai
Journal:  J Clin Med       Date:  2022-06-25       Impact factor: 4.964

4.  Down-regulation of hepatic HNF4alpha gene expression during hyperinsulinemia via SREBPs.

Authors:  Xuefen Xie; Hailing Liao; Huaixin Dang; Wei Pang; Youfei Guan; Xian Wang; John Y-J Shyy; Yi Zhu; Frances M Sladek
Journal:  Mol Endocrinol       Date:  2009-01-29

5.  Personalized approach of medication by indirect anticoagulants tailored to the patient-Russian context: what are the prospects?

Authors:  Liliya Alexandrovna Belozerceva; Elena Nikolaevna Voronina; Natalia Viktorovna Kokh; Galina Alexandrovna Tsvetovskay; Andrei Pavlovich Momot; Galina Israilevna Lifshits; Maxim Leonidovich Filipenko; Andrei Ivanovich Shevela; Valentin Viktorovich Vlasov
Journal:  EPMA J       Date:  2012-09-27       Impact factor: 6.543

6.  Evidence for a Role of the Transcriptional Regulator Maid in Tumorigenesis and Aging.

Authors:  Koichi Fujisawa; Shuji Terai; Toshihiko Matsumoto; Taro Takami; Naoki Yamamoto; Hiroshi Nishina; Makoto Furutani-Seiki; Isao Sakaida
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

7.  Identification of MyoD-Responsive Transcripts Reveals a Novel Long Non-coding RNA (lncRNA-AK143003) that Negatively Regulates Myoblast Differentiation.

Authors:  Yiwen Guo; Jingnan Wang; Mingfei Zhu; Rui Zeng; Zaiyan Xu; Guoliang Li; Bo Zuo
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

8.  Cyclin D1 Binding Protein 1 Responds to DNA Damage through the ATM-CHK2 Pathway.

Authors:  Yusuke Niwa; Kenya Kamimura; Kohei Ogawa; Chiyumi Oda; Yuto Tanaka; Ryoko Horigome; Masato Ohtsuka; Hiromi Miura; Koichi Fujisawa; Naoki Yamamoto; Taro Takami; Shujiro Okuda; Masayoshi Ko; Takashi Owaki; Atsushi Kimura; Osamu Shibata; Shinichi Morita; Norihiro Sakai; Hiroyuki Abe; Takeshi Yokoo; Akira Sakamaki; Hiroteru Kamimura; Shuji Terai
Journal:  J Clin Med       Date:  2022-02-06       Impact factor: 4.241

9.  An Id-like molecule, HHM, is a synexpression group-restricted regulator of TGF-beta signalling.

Authors:  Hiroaki Ikushima; Akiyoshi Komuro; Kazunobu Isogaya; Masahiko Shinozaki; Ulf Hellman; Keiji Miyazawa; Kohei Miyazono
Journal:  EMBO J       Date:  2008-10-16       Impact factor: 11.598

10.  GCIP functions as a tumor suppressor in non-small cell lung cancer by suppressing Id1-mediated tumor promotion.

Authors:  Kuan-yu Chen; Chao-chung Chen; Yau-lin Tseng; Yi-chien Chang; Ming-chung Chang
Journal:  Oncotarget       Date:  2014-07-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.